Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Interferon Alfa-2b in Stage IIB-III Melanoma (EORTC 18952)
NCT00002763Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 1996
- Modality
- Cytokines & Interferons
- Countries
- 21
01
Overview
A Phase 3 trial of interferon alfa-2b in melanoma, sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
interferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002763.